SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MedImmune

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Mortensen who wrote (18)3/30/1997 4:39:00 PM
From: Doug Meetmer   of 416
 
No, a limited supply in the face of increased demand will be a negative for Medimmune for years to come. It will put a cap on earnings.

An unlimited supply in the face of increased demand will be a huge positive for medimmune, just as long as there is no other competition.

Why do you think that Intel decided not to cut prices last fall? They know they have the monopoly and people will pay to have the product. They also have the production capabilities to keep up with demand. Apple Computer on the other hand lost market share and business in the past for not being able to keep up with demand.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext